Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T65667
(Former ID: TTDI01598)
|
|||||
Target Name |
PMN apoptosis and chemotaxis (PMNAC)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Rheumatoid arthritis [ICD-11: FA20] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | Synthetic neutrophil inhibitor peptide | Drug Info | Phase 1 | Rhinitis | [1] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Inhibitor | [+] 1 Inhibitor drugs | + | ||||
1 | Synthetic neutrophil inhibitor peptide | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Attenuation of interleukin 8-induced nasal inflammation by an inhibitor peptide. Am J Respir Crit Care Med. 2001 Apr;163(5):1198-205. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.